Targeted and Immunotherapies in Advanced Gastric Cancer: Key Data on Treatment Selection and AE Management

Share

Program Content

  • Advanced Gastric Cancer
    Targeted and Immunotherapies in Advanced Gastric Cancer: Key Data on Treatment Selection and AE Management
    Slideset
    Congratulations: You achieved a completion on 04/09/2022
    View Activity

Supporters

AstraZeneca

GlaxoSmithKline

Merck Sharp & Dohme Corp